Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Neurosurgery ; 88(2): 295-300, 2021 01 13.
Article in English | MEDLINE | ID: mdl-32893863

ABSTRACT

BACKGROUND: The role of enhanced recovery after surgery (ERAS) pathways implementation has not been previously explored in adult deformity patients. OBJECTIVE: To determine the impact of ERAS pathways implementation in adult patients undergoing open thoraco-lumbar-pelvic fusion for degenerative scoliosis on postoperative outcome, opioid consumption, and unplanned readmission rates. METHODS: In this retrospective single-center study, we included 124 consecutive patients who underwent open thoraco-lumbar-pelvic fusion from October 2016 to February 2019 for degenerative scoliosis. Primary outcomes consisted of postoperative supplementary opioid consumption in morphine equivalent dose (MED), postoperative complications, and readmission rates within the postoperative 90-d window. RESULTS: There were 67 patients in the ERAS group, and 57 patients served as pre-ERAS controls. Average patient age was 69 yr. The groups had comparable demographic and intraoperative variables. ERAS patients had a significantly lower rate of postoperative supplemental opioid consumption (248.05 vs 314.05 MED, P = .04), a lower rate of urinary retention requiring catheterization (5.97% vs 19.3%, P = .024) and of severe constipation (1.49% vs 31.57%, P < .0001), and fewer readmissions after their surgery (2.98% vs 28.07%, P = .0001). CONCLUSION: A comprehensive multidisciplinary approach to complex spine surgery can reduce opioid intake, postoperative urinary retention and severe constipation, and unplanned 90-d readmissions in the elderly adult population.


Subject(s)
Analgesics, Opioid/therapeutic use , Enhanced Recovery After Surgery , Postoperative Complications/prevention & control , Scoliosis/surgery , Spinal Fusion/methods , Adult , Aged , Female , Humans , Male , Middle Aged , Patient Readmission/statistics & numerical data , Postoperative Complications/epidemiology , Retrospective Studies , Spinal Fusion/adverse effects
2.
World Neurosurg ; 141: e888-e893, 2020 09.
Article in English | MEDLINE | ID: mdl-32561492

ABSTRACT

OBJECTIVE: The analysis of perioperative electronic patient portal (EPP) communication may provide risk stratification and insight for complication prevention in patients with affective disorders (ADs). We aimed to understand how patterns of EPP communication in patients with AD relate to preoperative narcotic use, surgical outcomes, and readmission rates. METHODS: The records of adult patients who underwent elective spinal surgery between January 2010 and August 2017 at a single institution were retrospectively reviewed for analysis. Primary outcomes included preoperative narcotic use, the number of perioperative EPP messages sent, rates of perioperative complications, hospital length of stay, emergency department (ED) visits within 6 weeks, and readmissions within 30 days after surgery. RESULTS: A total of 1199 patients were included in the analysis. Patients with an AD were more likely to take narcotics before surgery (51.69% vs. 41%, P < 0.001) and to have active EPP accounts (75.36% vs. 69.75%, P = 0.014) compared with controls. They were also more likely to send postoperative messages (38.89% vs. 32.75%, P = 0.030) and tended to send more messages (0.67 vs. 0.48, P = 0.034). The AD group had higher rates of postoperative complications (8.21% vs. 3.98%, P = 0.001), ED visits (4.99% vs. 2.43%, P = 0.009), and readmissions postoperatively (2.49% vs. 1.38%, P = 0.049). CONCLUSIONS: AD patients have specific patterns of perioperative EPP communication. They are at a higher risk of postoperative complications. Addressing these concerns early may prevent more serious morbidity and avoid unnecessary ED visits and readmissions, thus reducing costs and improving patient care.


Subject(s)
Anxiety/complications , Elective Surgical Procedures , Mood Disorders/complications , Patient Portals/statistics & numerical data , Postoperative Complications/diagnosis , Postoperative Complications/prevention & control , Spinal Diseases/surgery , Aged , Anxiety/psychology , Cohort Studies , Elective Surgical Procedures/psychology , Female , Humans , Male , Middle Aged , Mood Disorders/psychology , Retrospective Studies , Spinal Diseases/psychology
3.
World Neurosurg ; 138: 504-511.e8, 2020 06.
Article in English | MEDLINE | ID: mdl-32224269

ABSTRACT

OBJECTIVE: Spinal involvement in neurocysticercosis is rare and can lead to debilitating injury if not diagnosed and treated early. We aim to provide the reader with a thorough analysis of the best available evidence regarding patient characteristics, optimal treatment modality, and outcomes in cases of spinal neurocysticercosis. METHODS: A systematic review of the literature using PubMed, Google Scholar, and Web of Science electronic databases was made according to the PRISMA guidelines. An illustrative case of intramedullary-cervical spinal disease is also presented for illustrative purposes. RESULTS: A total of 46 reports of 103 patients fitting the screening criteria were identified. Isolated spinal involvement was seen in 46.15% of patients. Most infections (76.92%) had an intradural extramedullary localization, with 43.27% of cases involving >1 spinal cord level. The most common presenting symptoms were motor deficits (77.88%), pain syndromes (64.42%), and sensory deficits (53.85%). Combined surgical resection and pharmacologic therapy was the most frequently used treatment modality (49.04%) and had the highest proportion of patients reporting symptomatic improvement at follow-up (78.43%). Combination therapy had a significantly higher rate of neurologic recovery compared with surgery alone (P = 0.004) or medical treatment (P = 0.035). CONCLUSIONS: Spinal involvement in neurocysticercosis should be considered in patients from or who traveled to endemic areas presenting with ring-enhancing lesions. Combined treatment with surgery followed by cysticidal and steroid medication seems to be superior to surgery or medical treatment in isolation and seems to provide the highest chances of recovery.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Albendazole/therapeutic use , Anticestodal Agents/therapeutic use , Neurocysticercosis/therapy , Neurosurgical Procedures , Spinal Cord Diseases/therapy , Adult , Aged , Animals , Combined Modality Therapy , Humans , Hydrocephalus/etiology , Laminectomy , Magnetic Resonance Imaging , Middle Aged , Muscle Weakness/etiology , Neurocysticercosis/complications , Neurocysticercosis/diagnostic imaging , Neurocysticercosis/physiopathology , Pain/etiology , Recovery of Function , Somatosensory Disorders/etiology , Spinal Cord Diseases/complications , Spinal Cord Diseases/diagnostic imaging , Spinal Cord Diseases/physiopathology , Taenia solium , Treatment Outcome , Young Adult
4.
World Neurosurg ; 134: 584-593, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31734421

ABSTRACT

OBJECTIVE: Renal cell carcinoma (RCC) metastases to the intramedullary spinal cord carry a grim prognosis. The purpose of this review is to provide the reader with a comprehensive and systematic review of the current literature, and to present an illustrative case that would aid in the future management of similar scenarios. METHODS: A systematic review of the literature using the PubMed electronic database was made according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Only human clinical reports of intramedullary RCC metastasis were included. We also present an illustrative case that was treated at our institution. RESULTS: We identified 23 reports with a total of 31 patients. Of the tumors, 47% were located at the cervical level. Brain metastases were present in 41% of cases. Limb weakness (72%), urinary incontinence (41%), dysesthesia (47%), and localized spinal pain (38%) were the most frequently reported symptoms. Surgical resection alone was used in 34% of cases, followed by a combination of surgery and radiotherapy (31%), and radiotherapy alone (25%). Spinal metastases were detected an average of 32.1 months after the diagnosis of RCC, and mean patient survival after that was 8 months (range, 0-65 months). Reported survival after radiotherapy appeared to be the longest (11.2 months) compared with surgery (9.1 months) and combination therapy (5 months). CONCLUSIONS: Intramedullary spinal metastatic RCC is a rare entity with debilitating neurologic potential. Survival appears to be affected by the treatment method but is also likely influenced by the stage of discovery of the disease.


Subject(s)
Carcinoma, Renal Cell/diagnosis , Carcinoma, Renal Cell/therapy , Kidney Neoplasms/therapy , Spinal Cord Neoplasms/therapy , Carcinoma, Renal Cell/pathology , Combined Modality Therapy/methods , Humans , Kidney Neoplasms/diagnosis , Kidney Neoplasms/pathology , Prognosis , Spinal Cord Neoplasms/diagnosis , Spine/pathology , Spine/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...